Roche
Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in vitro diagnostics and a global supplier of transformative, innovative solutions across major disease areas. They are a global pioneer in pharmaceuticals and diagnostics, focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Latest Roche Content
News
Lab-Grown, Self-Sustainable Muscle Cells Repair Muscle Injury in Mice
Induced pluripotent stem cells have been used to make muscle stem cells that have been shown to repair muscle injury in mice.
News
Tackling Cancer by Stabilizing Chromosomes
Researchers have discovered that the enzyme Dicer, which is found in mammalian cells, plays a key part in the structural integrity of the genome.
News
Implementing Cellular Rejuvenation Therapy Reverses Signs of Aging in Mice
A combination of four reprogramming molecules that reset the epigenetic marks of older mice has been shown to reverse signs of aging with no side effects over time.
Product News
Element Biosciences Launches the AVITITM System To Democratize Access to Genomics
Element Biosciences Inc. has announced the commercial launch of the Element AVITI™ System, a benchtop sequencer offering an unrivaled combination of performance, cost and flexibility.
Industry Insight
Designing in Sustainability in Science
With a reliance on single-use plastics, significant waste and high energy usage, the carbon footprint of the biopharma industry is large. If we are to accelerate the path to net zero, it is therefore critical to ensure sustainability in science.
Industry Insight
Uncovering Real-World Patient Insights With Social Media and NLP
Historically, drug researchers have relied on methods such as focus groups and questionnaires for first-person accounts of patient-reported outcomes. Social media has emerged as a lower cost alternative that is increasingly accepted as a reputable source of information by the research community.
News
Omicron Resistant to Most Monoclonal Antibodies, but Neutralized by Booster
Scientists studied the sensitivity of the Omicron variant to monoclonal antibodies used in clinical practice to prevent severe forms of the disease in people at risk, as well as to antibodies in the blood of individuals previously infected with SARS-CoV-2 or vaccinated.
Advertisement
